Top Entrepreneurs’ Advice →
Founder and CEO, Acme Packet
Vice president, chief strategy and operating officer of the Texas Medical Center
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
Executive Partner, Sofinnova Ventures
CEO and Founder, Techstars
Managing Director, D.E. Shaw and Co., L.P.
Managing director, the Foundry Group
October 20, 2016 ·
October 27, 2016 ·
November 17, 2016 ·
NKT Therapeutics is developing drugs that target a class of immune cells known as natural killer T cells.
Company Leverages Wisconsin Resources to Take Flight
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2016, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.